Clinical data of patients with multiple sclerosis treated with glatiramer acetate
| Annual relapse rate at start | Annual relapse rate in study | EDSS at start of study | EDSS at end of study | |
| Lymph node swelling | 1.8 (1–3.5) | 0.33 (0–1) | 2.5 (0–3.5) | 2.5 (0–3.5) |
| No lymph node swelling | 1.5 (1–3.5) | 0.54 (0–1.8) | 2.5 (1–5) | 3 (0–6.5) |
Values are mean (relapse rate) or median (EDSS) (range).